Photo by goian from unsplash
Sign Up to like & get
recommendations!
0
Published in 2017 at "Hematological Oncology"
DOI: 10.1002/hon.2439_97
Abstract: Introduction—Post-transplant lymphoproliferative disease (PTLD) is a life-threatening complication of solid organ transplantation (SOT). Histologic heterogeneity and lack of treatment standards have made evaluating clinical outcomes in specific patient populations difficult. This systematic literature review investigates…
read more here.
Keywords:
post transplant;
lymphoproliferative disorder;
subtype survival;
transplant lymphoproliferative ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2019 at "European Journal of Nuclear Medicine and Molecular Imaging"
DOI: 10.1007/s00259-019-04486-2
Abstract: Aim/Introduction: One of the most dire complications of hematopoietic stem cell (HSCT) and solid organ transplantation (SOT) is the development of post-transplant lymphoproliferative disorder (PTLD). PTLD compromises a broad spectrum of disorders classified by the…
read more here.
Keywords:
ptld;
fdg pet;
lymphoproliferative disorder;
post transplant ... See more keywords
Photo by goian from unsplash
Sign Up to like & get
recommendations!
0
Published in 2020 at "Virchows Archiv"
DOI: 10.1007/s00428-020-02985-4
Abstract: Post-transplant lymphoproliferative disorders (PTLD) occur after solid organ transplantation (SOT) or hematopoietic stem cell transplantation (HCT) and are frequently associated with Epstein-Barr virus (EBV). Because of the complex immune setup in PTLD patients, the tumor…
read more here.
Keywords:
post transplant;
transplantation;
ptld;
post ... See more keywords
Photo by goian from unsplash
Sign Up to like & get
recommendations!
0
Published in 2021 at "American Journal of Ophthalmology Case Reports"
DOI: 10.1016/j.ajoc.2021.101186
Abstract: Purpose Post-transplant lymphoproliferative disorder (PTLD) represents a spectrum of disorders associated with Epstein Barr Virus infection in up to 80% of cases in the setting of pharmacologic immunosuppression following hematopoietic stem cell or solid organ…
read more here.
Keywords:
epstein barr;
barr virus;
post transplant;
lymphoproliferative disorder ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2019 at "Transplantation proceedings"
DOI: 10.1016/j.transproceed.2019.04.061
Abstract: Post-transplant lymphoproliferative disorder (PTLD) can be Epstein-Barr virus (EBV)-positive lymphoproliferations occurring in the first year after transplantation or EBV-negative lymphoma occurring many years after transplantation. Both B-cell and T-cell type of PTLD are described in…
read more here.
Keywords:
appendix mimicking;
acute appendicitis;
transplant lymphoproliferative;
post transplant ... See more keywords
Photo from wikipedia
Sign Up to like & get
recommendations!
0
Published in 2022 at "Transplantation proceedings"
DOI: 10.1016/j.transproceed.2021.11.011
Abstract: Post-transplant lymphoproliferative disease (PTLD) is a life-threatening complication among kidney transplant recipients. The clinical presentation of patients with PTLD is highly variable. The type of PTLD and the area of involvement determine its presentation, which…
read more here.
Keywords:
post transplant;
transplant lymphoproliferative;
renal transplant;
intestinal obstruction ... See more keywords
Photo by cdc from unsplash
Sign Up to like & get
recommendations!
0
Published in 2021 at "Medicine"
DOI: 10.1097/md.0000000000024047
Abstract: Abstract Introduction: Post-transplant lymphoproliferative disease (PTLD) is a series of proliferative diseases of the lymphatic system. Among patients receiving hematopoietic stem cell transplantation (HSCT), PTLD is a prevalent complication that severely affects rates of survival.…
read more here.
Keywords:
diagnosis;
ptld;
lymphoproliferative disease;
post transplant ... See more keywords
Photo from wikipedia
Sign Up to like & get
recommendations!
0
Published in 2023 at "Journal of pediatric hematology/oncology"
DOI: 10.1097/mph.0000000000002629
Abstract: Post-transplant lymphoproliferative disorder (PTLD) is a complication of immunosuppressive therapy following solid organ or hematopoietic cell transplantation. Initial treatment typically includes a reduction of immunosuppression with or without rituximab. However, the optimal therapy for PTLD…
read more here.
Keywords:
therapy;
post transplant;
plasmacytic differentiation;
lymphoproliferative disorder ... See more keywords
Photo by goian from unsplash
Sign Up to like & get
recommendations!
0
Published in 2017 at "British Journal of Haematology"
DOI: 10.1111/bjh.14272
Abstract: & J.W. Vardiman), pp. 343–349. IARC, Lyon. Trappe, R., Oertel, S., Leblond, V., Mollee, P., Sender, M., Reinke, P., Neuhaus, R., Lehmkuhl, H., Horst, H.A., Salles, G., Morschhauser, F., Jaccard, A., Lamy, T., Leithauser, M.,…
read more here.
Keywords:
post transplant;
transplant lymphoproliferative;
lymphoproliferative disorder;
Photo by goian from unsplash
Sign Up to like & get
recommendations!
0
Published in 2018 at "British Journal of Haematology"
DOI: 10.1111/bjh.15263
Abstract: The post‐transplant lymphoproliferative disorders (PTLDs) are a heterogeneous group of neoplasms that are one of the most serious complications of bone marrow and solid organ transplants. Because these disorders are rare, there are no randomized…
read more here.
Keywords:
management;
post transplant;
lymphoproliferative disorders;
transplant lymphoproliferative ... See more keywords
Photo by goian from unsplash
Sign Up to like & get
recommendations!
0
Published in 2020 at "British Journal of Haematology"
DOI: 10.1111/bjh.16304
Abstract: Post‐transplant lymphoproliferative disorder (PTLD) may arise after solid organ transplantation, and the most common subtype resembles diffuse large B cell lymphoma (DLBCL). In DLBCL‐type PTLD, the anti‐CD20 antibody rituximab (R) may be combined with chemotherapy…
read more here.
Keywords:
post transplant;
lymphoproliferative disorder;
ptld;
type ... See more keywords